Effect of formoterol addition on dynamic hyperinflation during 6-minute walk test (6MWT) in moderate to severe COPD Source: Annual Congress 2007 - Treatment of COPD Year: 2007
Glucocorticosteroid reversibility testing with oral prednisone (²steroid trial²) for 4 weeks: time-response study using serial spirometry and 6-minute walk distance (6MWD) in patients with moderate to severe stable COPD Source: Eur Respir J 2004; 24: Suppl. 48, 429s Year: 2004
Is 6-min walk distance more helpful than FEV1 in evaluating severe COPD patients? Source: ISSN=ISSN 1810-6838, ISBN=, page=68 Year: 2007
Predictors for longitudinal change in 6-minute walk distance in COPD patients Source: Annual Congress 2012 - Outcomes and assessment methods in physiotherapy and rehabilitation Year: 2012
Interpretation of treatment changes in 6-minute walk distance in patients with COPD Source: Eur Respir J 2008; 32: 637-643 Year: 2008
Six-min walk distance test better reflects maximal exercise tolerance in severe, but not in mild COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 356s Year: 2001
The 6-min walk distance: change over time and value as a predictor of survival in severe COPD Source: Eur Respir J 2004; 23: 28-33 Year: 2004
Inhibitory effect of SABA on exercise dynamic lung hyperinflation during 6-min walk test in stable COPD patients Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation Year: 2011
Impact of pulmonary rehabilitation on six-minute walk distance in patients with very severe COPD Source: Annual Congress 2010 - Pulmonary rehabilitation: understanding and developing the intervention Year: 2010
Predictors of six-minute walk distance at baseline and after three years in COPD patients Source: Annual Congress 2011 - Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation Year: 2011
Evaluating impairment in exercise capacity in COPD patients with the six-minute walk distance test: a comparative study Source: Eur Respir J 2006; 28: Suppl. 50, 767s Year: 2006
The six minute walk distance is the best predictor of physical activity in severe COPD patients Source: International Congress 2017 – Assessing functional outcomes in chronic respiratory disease Year: 2017
Why do COPD patients improve six minute walking distance (6MWD) with the use of a rollator? Source: Eur Respir J 2003; 22: Suppl. 45, 330s Year: 2003
The impact of body composition on walking distance in the six-minute walk test in COPD patients Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008
The 6-min walking distance: long-term follow up in patients with COPD Source: Eur Respir J 2007; 29: 535-540 Year: 2007
The distance walked in the 6-minute walk test (6MWT) by cases of rhinitis, asthma, and COPD vs. controls: A preliminary report Source: Annual Congress 2010 - Methods in respiratory epidemiology Year: 2010
Degree of exercise limitation in COPD: impact on 6 minute walk (6MW) in response to long-acting β-agonist (LABA) treatment Source: Eur Respir J 2007; 30: Suppl. 51, 76s Year: 2007
Relationship between IL-6 and FEV1 interaction and six minute walk distance (6MWD) performance in COPD patients Source: Annual Congress 2008 - Physiological response to exercise performance Year: 2008
Activities of daily living capacity is better predicted by 6MWD than by maximal exercise test in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 329s Year: 2003
The 6-minute walking distance parameters in COPD patients during biennium research Source: Eur Respir J 2006; 28: Suppl. 50, 807s Year: 2006